Postconditioning and Debio-025 Prevent LV Remodelling and Reduce Mortaility Following Acute Myocardial Infarction in Mice | Debio 025 | /

Home|Careers|Contact us

Welcome

At a glance

Social responsibility

Our companies

Business Model

Development capabilites

News

27.04.2010
Debiopharm Group™ starts Phase I clinical trial with Debio 0932
26.04.2010
Two New Tenants for EPFL’s Innovation Square

Postconditioning and Debio-025 Prevent LV Remodelling and Reduce Mortaility Following Acute Myocardial Infarction in Mice

L. Gomez, H. Thibault, L. Argaud, O. Gateau-Roesch, J.M. Dumont, G. Vuagniaux, G. Derumeaux, M. Ovize

World Congress of Cardiology - Sept 2006 - Barcelona/Spain (Abstract + Poster)

pdf Poster